Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure.
about
Managing renal complications in multiple myeloma.Current treatments for renal failure due to multiple myeloma.Autologous stem cell transplant for multiple myeloma patients 70 years or older.Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival.Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis.Stem cell mobilization in patients with dialysis-dependent multiple myeloma: Report of the Polish Myeloma Study Group.Cell-Based Therapies: The Nonresponder
P2860
Q38900024-8401F66C-940C-475F-93B7-8CEE19D3F12FQ38959138-D2806B6F-69AD-4E2D-8217-364EFBD49454Q39633772-F81A9FC4-8ADC-4F3B-B371-2877450D3FC5Q39763521-91F2BD95-B07E-49A4-88C5-6F8CE80E756CQ45067612-31FA4C4F-8607-4344-96F9-87248B172754Q47967442-6D3E1CDE-4272-4788-B714-6F1F3050883EQ58696783-4FD20DCE-DBDE-40EF-A50A-0E0A0017CA5D
P2860
Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Efficacy, toxicity and mortali ...... lysis-dependent renal failure.
@en
type
label
Efficacy, toxicity and mortali ...... lysis-dependent renal failure.
@en
prefLabel
Efficacy, toxicity and mortali ...... lysis-dependent renal failure.
@en
P2093
P2860
P356
P1476
Efficacy, toxicity and mortali ...... lysis-dependent renal failure.
@en
P2093
E Masih-Khan
L Chodirker
R St Bernard
P2860
P2888
P356
10.1038/BMT.2014.226
P407
P577
2014-10-06T00:00:00Z
P5875
P6179
1019613006